CD4 and inflammatory breast carcinoma: These cells were used to explore the impact of tumor Sdc-1 silencing on polarization of CD4+ T cells isolated from non-IBC (under direct and indirect co-culture conditions) and IBC patients (under indirect co-culture conditions) towards Th1, Th2, Th17 and Treg subsets.